

Laureate Education vs Afya
Laureate Education operates a network of higher-education institutions across Latin America and Europe with a portfolio approach to emerging market academic demand, while Afya is laser-focused on medical education in Brazil, a country with structurally insufficient physician supply relative to its population that creates durable pricing power for credentialed seats. Both companies found a profitable formula in for-profit education within emerging markets where public capacity consistently falls short of demand and students prioritize career-outcome programs. Laureate Education vs Afya compares unit economics, regulatory risk exposure, and organic growth potential to determine which company has built the more durable and scalable academic business model.
Laureate Education operates a network of higher-education institutions across Latin America and Europe with a portfolio approach to emerging market academic demand, while Afya is laser-focused on medi...
Investment Analysis
Pros
- Laureate Education increased its full-year 2025 guidance and authorized a $150 million share repurchase program, reflecting confidence in operational performance.
- The company reported a 5.55% revenue growth in 2024 to $1.57 billion and a significant 175.56% increase in earnings, indicating improving profitability.
- Laureate has a diverse presence across multiple countries with over 470,000 students enrolling in various undergraduate, graduate, and specialized programs through online and campus-based formats.
Considerations
- The forward price-to-earnings ratio of about 14 suggests a moderate valuation but price targets vary, indicating some analyst uncertainty regarding future stock performance.
- Its stock price has a relatively low beta (around 0.61), which may imply limited stock price volatility but also less upside potential in bullish markets.
- Despite increased earnings, the company does not currently pay dividends, which may deter income-focused investors.

Afya
AFYA
Pros
- Afya Ltd is Brazil's leading medical education group with a multifaceted education portfolio including undergrad, continuing education, and medical practice solutions.
- The company shows solid liquidity ratios such as a quick ratio of 1.38 and current ratio of 1.42, supporting short-term financial stability.
- Afya offers diversified services in healthcare education and clinical management, creating synergy and broadening market opportunities in Brazil's growing education sector.
Considerations
- Afya's market capitalization at approximately $1.28 billion is significantly smaller than some peers, which could reflect relatively limited scale and competitive positioning.
- The company’s interest coverage ratio of 2.76 indicates moderate leverage, suggesting potential risk in rising interest rate environments or economic downturns.
- Trading volumes and average daily liquidity are relatively low, which could lead to higher volatility and less efficient pricing in its stock.
Buy LAUR or AFYA in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


